化学療法を併用した膀胱全摘除術の経験 (第2回泌尿器がん化学療法研究会学術集会)
スポンサーリンク
概要
- 論文の詳細を見る
Seven cases of advanced bladder cancer patients were treated with FT-207 administration preand post operatively as surgical adjuvant chemotherapy. Clinical laboratory data and the concentration of FT-207 and 5-FU in serum and tumor tissue were examined in all cases except one who had developed drug eruption. Severe side effect was not observed. The serum concentration of FT-207 and 5-FU begin to decrease in three hours after the intravenous administration of FT-207 (1,200 mg) and the concentration of FT-207 in bladder cancer tissue decreased slowly, but that of 5-FU in tumor tissue increased with the lapse of time. The theoretical meanings of surgical adjuvant chemotherapy for bladder cancer are discussed briefly.
- 泌尿器科紀要刊行会の論文
泌尿器科紀要刊行会 | 論文
- MVAC療法後の転移性尿路上皮癌に対するGemcitabine, Docetaxel, Carboplatin併用化学療法の検討
- Grade 3 Ta-1表在性膀胱癌に対する膀胱温存治療
- 腹腔鏡下に摘出した後腹膜神経線維腫の1例
- 移植腎生検による腎内動脈瘤破裂の1例
- Modified M-VAC療法後に残存腫瘍切除を施行した進行尿路上皮癌患者の治療成績